How many institutions own OTLC stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own OTLC shares is 0, representing N/A of the company's common stock.

Who are the major shareholders selling Oncotelic Therapeutics, Inc. stock?

N/A, in the last quarter, reduced its stake in OTLC by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the OTLC shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned OTLC shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying OTLC stock?

As per its latest 13F filing, N/A increased its stake in OTLC by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of OTLC to its portfolio, raising its holding to - shares of worth -. N/A also increased its OTLC shares holding by N/A which brought its holding to - shares worth -.

OTLC's major insiders: who are they?

The insider with the most stakes in OTLC is Trieu Vuong , CHAIRMAN AND CEO at the company. Additionally, OTLC stock is highly held by CHIEF TECHNOLOGY OFFICER Park Chulho and director SODERBERG PER OLOF among others.

Did an insider recently sell OTLC stock?

Company executives, directors, and other insiders own 50.55% percent of Oncotelic Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which OTLC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include HOWSON TAMAR D.

Which insider recently purchased OTLC stock?

There have been 2 transaction(s) during the past 6-months in which Oncotelic Therapeutics, Inc. insiders have bought stock, totalling 335759 shares

How much of OTLC does insiders own?

Around 187.02M Oncotelic Therapeutics, Inc. shares are held by insiders, which represents about 50.55% of OTLC stock.

Who is the insider with the largest stake?

OTLC CHAIRMAN AND CEO, Trieu Vuong holds the largest portfolio of the company's shares. OTLC shares owned by Trieu total nearly 93.63 million.

Which institution holds the most shares in OTLC?

N/A is the largest institutional owner in OTLC which holds - shares worth - or N/A of the total OTLC shares outstanding followed by N/A with ownership of - shares representing N/A of the OTLC ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Is Oncotelic Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the OTLC is concerned, it is a stock which is not optionable.

Is there a short position on OTLC's shares?

Number of OTLC shares short is 662.75K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding OTLC shares are there?

As of today, 408.29M shares of OTLC are outstanding.

Is there many float in OTLC stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, OTLC has 214.45M shares in float.

OTLC short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for OTLC is 8.04.

Oncotelic Therapeutics (OTLC) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares2.5

Short Percent Of Float2.5

Shares Outstanding408.29M

Shares Float214.45M

Shares Short662.75K

Short Ratio8.04

2.5%

Short % of Float

2.5%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

50.55% Percentage of Shares held by All Insiders

N/A Percentage of Shares held by All Institutions

N/A Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
No Data

Insiders

Among the OTLC insiders holding of 50.55% of the stake in company, TRIEU VUONG, CHAIRMAN AND CEO, holds the largest shares of 93.63M. PARK CHULHO, CHIEF TECHNOLOGY OFFICER, is the second largest OTLC insider with ownership of 2.83M shares. SODERBERG PER OLOF, director, stands third with possession of 650K shares of that stake.

Insiders	Designation	Shares Held
TRIEU VUONG	CHAIRMAN AND CEO	93.63M
PARK CHULHO	CHIEF TECHNOLOGY OFFICER	2.83M
SODERBERG PER OLOF	director	650K
CITRON JOEL TOMAS	director	315.58K
SCHWIETERMAN WILLIAM D	President and CEO	312.5K
LAFFER ARTHUR B	director	310.14K
SHIEBLER WILLIAM N	director	186K
LOAR MATTHEW M	Chief Financial Officer	125K
REYNOLDS DONALD ROGERS	director	125K
CHIN RICHARD	President and CEO	61.17K
FICKLING ROY H	director	60K
SHAH AMIT B.	CHIEF FINANCIAL OFFICER	60K
HOWSON TAMAR D	director	50K
ZECHER RICHARD	director	49.3K
LANGECKER PETER	Chief Executive Officer	5K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 17, 2026	TRIEU VUONG	PURCHASE	0.04	239.76K	10.69K	93.63M
Jun 15, 2026	TRIEU VUONG	PURCHASE	0.04	96K	4.32K	93.39M
Jul 10, 2025	TRIEU VUONG	PURCHASE	0.01	104K	520	93.29M
Jul 09, 2025	TRIEU VUONG	PURCHASE	0.01	1	0.01	93.29M
Jul 08, 2025	TRIEU VUONG	PURCHASE	0.01	94.74K	473.68	93.39M
Jan 31, 2025	TRIEU VUONG	PURCHASE	0.03	63.78K	1.79K	93.19M
Jan 30, 2025	TRIEU VUONG	PURCHASE	0.03	100K	2.8K	93.13M
Jan 29, 2025	TRIEU VUONG	PURCHASE	0.03	183.07K	5.13K	93.03M
Nov 22, 2024	TRIEU VUONG	PURCHASE	0.03	298.5K	8.63K	92.84M
Aug 23, 2024	TRIEU VUONG	PURCHASE	0.02	500K	10K	92.54M
Jun 29, 2023	TRIEU VUONG	PURCHASE	0.02	425K	8.93K	92.04M
Jun 28, 2023	TRIEU VUONG	PURCHASE	0.03	75K	1.95K	91.62M
Jun 16, 2023	TRIEU VUONG	PURCHASE	0.03	100K	2.6K	91.54M
Jun 14, 2023	TRIEU VUONG	PURCHASE	0.03	400K	13.04K	91.44M
May 26, 2023	TRIEU VUONG	PURCHASE	0.03	126.89K	4.33K	91.04M
May 02, 2023	TRIEU VUONG	PURCHASE	0.04	100K	4.5K	90.92M
Dec 06, 2022	TRIEU VUONG	PURCHASE	0.05	120K	6K	90.56M
Nov 22, 2022	TRIEU VUONG	PURCHASE	0.08	70K	5.6K	90.44M
Sep 26, 2022	TRIEU VUONG	PURCHASE	0.07	20K	1.36K	90.37M
Aug 25, 2022	TRIEU VUONG	PURCHASE	0.08	80K	6.56K	90.35M
Nov 24, 2020	SHAH AMIT B.	PURCHASE	0.19	8.22K	1.56K	60K
Nov 23, 2020	SHAH AMIT B.	PURCHASE	0.19	20.09K	3.82K	51.78K
Nov 20, 2020	SHAH AMIT B.	PURCHASE	0.20	31.69K	6.18K	31.69K
Nov 19, 2020	TRIEU VUONG	PURCHASE	0.19	50.5K	9.6K	15.81M
Nov 19, 2020	PARK CHULHO	PURCHASE	0.18	22.17K	4.1K	2.83M
Mar 26, 2020	TRIEU VUONG	PURCHASE	0.12	3K	360	15.76M
Apr 12, 2018	SCHWIETERMAN WILLIAM D	PURCHASE	0.40	312.5K	125K	312.5K
Apr 12, 2018	LOAR MATTHEW M	PURCHASE	0.40	125K	50K	125K
Apr 12, 2018	REYNOLDS DONALD ROGERS	PURCHASE	0.40	125K	50K	125K
Dec 16, 2016	REYNOLDS DONALD ROGERS	PURCHASE	0.34	12.7K	4.32K	12.7K
Jun 28, 2013	LANGECKER PETER	PURCHASE	2.75	3K	8.25K	5K
Jul 01, 2010	HOWSON TAMAR D	SALE	0.39	25K	9.75K	50K
Aug 10, 2007	FICKLING ROY H	PURCHASE	3.58	7K	25.06K	60K
Aug 09, 2007	FICKLING ROY H	PURCHASE	3.58	3K	10.74K	53K
Aug 07, 2007	FICKLING ROY H	PURCHASE	3.60	4.5K	16.2K	50K
Aug 06, 2007	FICKLING ROY H	PURCHASE	3.60	5.5K	19.78K	45.5K
May 02, 2007	SHIEBLER WILLIAM N	PURCHASE	4.60	3.3K	15.18K	186K
May 01, 2007	SHIEBLER WILLIAM N	PURCHASE	4.48	200	896	161.2K
Dec 15, 2006	SODERBERG PER OLOF	PURCHASE	4.94	65.8K	325.05K	650K
Dec 05, 2006	SODERBERG PER OLOF	PURCHASE	5.02	100K	502K	584.2K
Nov 22, 2006	CITRON JOEL TOMAS	PURCHASE	4.31	60	258.6	315.58K
Nov 21, 2006	CITRON JOEL TOMAS	PURCHASE	4.12	100	412	311.08K
Sep 15, 2006	CHIN RICHARD	PURCHASE	4.02	1.17K	4.69K	61.17K
Aug 31, 2006	SODERBERG PER OLOF	PURCHASE	3.53	53.4K	188.5K	484.2K
Aug 30, 2006	SODERBERG PER OLOF	PURCHASE	3.43	30.8K	105.64K	430.8K
Aug 01, 2006	CHIN RICHARD	PURCHASE	3.29	2.83K	9.32K	42.83K
Aug 01, 2006	SHIEBLER WILLIAM N	PURCHASE	3.24	16.91K	54.77K	148.6K
Jul 31, 2006	SHIEBLER WILLIAM N	PURCHASE	3.16	100	316	101.1K
Jul 28, 2006	LAFFER ARTHUR B	PURCHASE	3.07	50K	153.72K	310.14K
Mar 16, 2006	ZECHER RICHARD	PURCHASE	3.96	4.3K	17.03K	49.3K
Mar 15, 2006	SODERBERG PER OLOF	PURCHASE	3.95	50K	197.5K	400K
Mar 07, 2006	CITRON JOEL TOMAS	PURCHASE	3.86	400	1.54K	292.98K
Mar 06, 2006	CITRON JOEL TOMAS	PURCHASE	3.89	300	1.17K	291.28K
Mar 03, 2006	LAFFER ARTHUR B	PURCHASE	3.85	50K	192.3K	260.14K
Sep 16, 2005	SODERBERG PER OLOF	PURCHASE	5.09	100K	509K	350K
Aug 15, 2005	LAFFER ARTHUR B	PURCHASE	4.58	6.8K	31.14K	210.14K
Aug 12, 2005	LAFFER ARTHUR B	PURCHASE	4.61	10K	46.1K	203.34K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE335.76K2

SALES00

NET SHARES335.76K2

SHARES HELD187.02M2

% NET SHARES-99.82%0%

OTLC Stock Ownership Breakdown